Valgimigli, Marco <br/><br/>
Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial.  [electronic resource] 

 -  American heart journal  Jul 2007 
 - 39-45 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1016/j.ahj.2007.03.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Antibodies, Monoclonal--administration & dosage<br/>Clinical Trials, Phase III as Topic<br/>Drug Administration Schedule<br/>Follow-Up Studies<br/>Humans<br/>Immunoglobulin Fab Fragments--administration & dosage<br/>Infusions, Intravenous<br/>Metals<br/>Myocardial Infarction--therapy<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Randomized Controlled Trials as Topic<br/>Research Design<br/>Sirolimus--administration & dosage<br/>Stents<br/>Tirofiban<br/>Tyrosine--administration & dosage